ABBV trade ideas
$ABBV Short PositionFor the public record -- I've taken a short position on $ABBV this morning at $74.32
My reasons are technical, and not sociopolitical, but are too complex to describe on one chart, so I'll not attempt to do so.
My opinions and actions are not recommendations to buy or sell any stock, bond, ETF, commodity, or any other financial instrument.
ABBV - Buy Position @68.00 Setup Great Buy Position @68 flat. Great yield, great risk to reward ratio. Unfortunately the correction might be cause by the dividend payout, so will finish after the divided payment. Great Investing Entry Point, No TRADE!
ABBV - Strong Buy!I dream to see the formation of the right shoulder. If will give-I will buy without hesitation. The asset is charged powerfully for growth.The wave analysis also gives a good hope to see a decrease within the 2nd wave of growth and, as a consequence, the formation of the right shoulder. Note that the largest volume falls on the 3rd wave, which is one of the main indicators of determining the sub-waves
ABBV - Strong Buy!I dream to see the formation of the right shoulder. If will give-I will buy without hesitation. The asset is charged powerfully for growth.The wave analysis also gives a good hope to see a decrease within the 2nd wave of growth and, as a consequence, the formation of the right shoulder. Note that the largest volume falls on the 3rd wave, which is one of the main indicators of determining the sub-waves
ABBV with a possible ~3.7% movementThe candle for friday closed green above the cloud and we have an uptrending pattern with the tk crossover. I think it will run up about 3.7% and stop around $75ish which is where we saw previous resistance action on 7/3/19, 7/24/17, and there's the sharp chikou pattern at that price level on 5/28/19.
AbbVie Receives FDA Approval of MAVYRET® (glecaprevir/pibrentasvABBV: AbbVie
2019-09-26 20:00:00
AbbVie Receives FDA Approval of MAVYRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks for Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis Across All Genotypes
shortComing into long term downtrend resistance. Currently at gap but not pushing through and at .618 retracement. Looking for quick short. With S$P looking shaky, we might see more sell pressure
ABBV - Test the trendlineAs we can see from the chart, the price now is testing the bearish trendline which had stood for months. Besides, ABBV crossed the 70, the old resistance which can only be seen if switching to Weekly chart. Next, the price now is being supported by a bullish trendline.
There are 2 strategies:
1. Wait for the price to test the up-ward trendline again, and start a long position.
2. Wait for the price to break the bearish trendline, and go long
The target price for both is 76 - to close the gap and meet a strong resistance these months in 2019.
ABBV long setupABBV’s innovation outlook is trending up based on a current score of 70 out of 99, outperforming sector average. Jobs growth over the past year has decreased and insiders sentiment is positive. ABBV is an Outperformer in terms of sustainability. It is most exposed to AstraZeneca PLC as its supplier. Over the past 4 quarters ABBV beat earnings estimates 3 times and it pays dividend higher than its peers.
For more analysis and articles visit our website.
ABBV | POT Stock I think it's time to start gaining a position on one of the most popular pot shares
ABBV - Might be finished, so now what.For this to work, the price dips into the blue lines and up to the green just under $80 for a 1-3 month play.
Good time to buy ABBVIEChart Analyse
Based on weekly and monthly chart, we can see an interesting point in the ABBVIE chart.
The weekly chart is showing a nice low currently forming. Lets see how we end this week.
And if we look at the long term trend, the low sits exactly on the long term trend line.
If we look at the monthly timeframe you can see also a nice candle forming. we still have a week to go this month, so lets see what happens.
Additionally, this corresponds to Fibonacci zone 78.6
Dividend
currently 6.4 % Dividend
6 year growth history
good payout ratio
1 year dividend growth 27 %
$ABBV Good stock but hold your cash.No need to catch the falling knife on $ABBV. Great dividend stock and a very big player. Still a nice entry if its your retirement fund stock.
ABBV REVERSALLooking to stay above the descending trend line and also to break .236 Fib extension @ 65.66 to go long. Short term PT $74.96
ABBV brokeout and maintained to stay above VWAP (65.05): BUYDIPSLooks like we have a reversal forming. If ABBV maintains above 65.05 on a S&P down day buy every dip.
Rejected at 65.15, needs to maintain above for morningstar We need confirmation of the oversold reversal in progress !
Positive pipeline and sales will push this to USD 80 fastChanging fundamentals for ABBV and oversold conditions make this an extremely favorable buy on risk vs. reward. Im in with 1500 shares
